Abattis Bioceuticals (ATT) Sets New 52-Week Low at $0.07

Abattis Bioceuticals Corp (CNSX:ATT)’s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.07 and last traded at C$0.08, with a volume of 1458722 shares trading hands. The stock had previously closed at C$0.08.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by Enterprise Leader and is the sole property of of Enterprise Leader. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://theenterpriseleader.com/2019/02/06/abattis-bioceuticals-att-sets-new-52-week-low-at-0-07.html.

About Abattis Bioceuticals (CNSX:ATT)

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets.

See Also: Coverage Ratio

Receive News & Ratings for Abattis Bioceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abattis Bioceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply